Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Battle Over Deferred Drug Listings In Australia: Should Cost-Effective Drugs Always Be Funded?

This article was originally published in PharmAsia News

Executive Summary

A storm is brewing in the lead up to Australia's May 10 federal budget over the nation's Pharmaceutical Benefits Scheme, which acts as a single payer to subsidize drug prices and is administered by the government

You may also be interested in...



As Global Payers Become Monopolies, Biopharma Need To Demonstrate Value Earlier – AusBiotech Conference

Biopharma companies should define value propositions early and have a case for value differentiation at the discovery stage if they want to make a case to payers.

Will More Subsidies For New Drugs Be A Core Promise Of New Australian Government?

A new government in Australia faces a budget gap that will soon bring health care reimbursement with industry focused on a pledge by the Liberal Party to restore the independence of the Pharmaceutical Benefits Advisory Committee.

What Impact Will Sept. 7 Australian Election Have On Pharma Industry?

Australia’s Federal Election is on Sept. 7, and both Medicines Australia and AusBiotech have been lobbying the Labor and the Liberal National parties to see what the incoming government can offer the pharmaceutical, medical device and biotechnology industries.

Related Content

UsernamePublicRestriction

Register

ID1122434

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel